The company is now reportedly planning to offer 7 million shares at a price range of $24 to $25, up from the original planned offering of 6 million shares at $20 to $23. As such, the total amount raised could increase from approximately $129 million to $172 million.
The company will be traded on the Nasdaq stock market under the symbol HCAT. It is expected to go public on July 25.
More articles on data analytics:
Healthcare software company Phreesia goes public: 3 things to know
Atrium Health deploys automation, data analytics for medication management
How Johns Hopkins boosted data sharing between patients, clinicians: CMIO Dr. Peter Greene
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
